SF3B1 and myelodysplastic syndrome: Somatic mutations in SF3B1 are particularly prevalent in myelodysplastic syndromes (MDS) [9–11,26] and CLL [16,18], as well as in other solid tumors, such as UVM, pancreatic ductal adenocarcinomas and breast cancers [19,20,27].